ArticleFrontiers in oncology2025
BrainTumNet: multi-task deep learning framework for brain tumor segmentation and classification using adaptive masked transformers.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Multimodal imaging and AI in brain tumor surgery: current tools and emerging integration.npj biomedical innovations · 2026Review
- Deep Learning for Brain Tumour Analysis: A Systematic Review of CNN-Transformer Hybrids in Multimodal Imaging.International journal of biomedical imaging · 2026Review
- Interpretability and performance of a 3D C-vit model for accurate grading of pediatric brain tumors.Frontiers in oncology · 2026Article
- Comparing Handcrafted Radiomics Versus Latent Deep Learning Features of Admission Head CT for Hemorrhagic Stroke Outcome Prediction.Biotech (Basel (Switzerland)) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and objective: Accurate diagnosis of brain tumors significantly impacts patient prognosis and treatment planning. Traditional diagnostic methods primarily rely on clinicians' subjective interpretation of medical images, which is heavily dependent on physician experience and limited by time consumption, fatigue, and inconsistent diagnoses. Recently, deep learning technologies, particularly Convolutional Neural Networks (CNN), have achieved breakthrough advances in medical image analysis, offering a new paradigm for automated precise diagnosis. However, existing research largely focuses on single-task modeling, lacking comprehensive solutions that integrate tumor segmentation with classification diagnosis. This study aims to develop a multi-task deep learning model for precise brain tumor segmentation and type classification. Methods: The study included 485 pathologically confirmed cases, comprising T1-enhanced MRI sequence images of high-grade gliomas, metastatic tumors, and meningiomas. The dataset was proportionally divided into training (378 cases), testing (109 cases), and external validation (51 cases) sets. We designed and implemented BrainTumNet, a deep learning-based multi-task framework featuring an improved encoder-decoder architecture, adaptive masked Transformer, and multi-scale feature fusion strategy to simultaneously perform tumor region segmentation and pathological type classification. Five-fold cross-validation was employed for result verification. Results: In the test set evaluation, BrainTumNet achieved an Intersection over Union (IoU) of 0.921, Hausdorff Distance (HD) of 12.13, and Dice Similarity Coefficient (DSC) of 0.91 for tumor segmentation. For tumor classification, it attained a classification accuracy of 93.4% with an Area Under the ROC Curve (AUC) of 0.96. Performance remained stable on the external validation set, confirming the model's generalization capability. Conclusion: The proposed BrainTumNet model achieves high-precision diagnosis of brain tumor segmentation and classification through a multi-task learning strategy. Experimental results demonstrate the model's strong potential for clinical application, providing objective and reliable auxiliary information for preoperative assessment and treatment decision-making in brain tumor cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.